Immunohistochemical study of various types of pterygium in patients of the Southern Urals
https://doi.org/10.15789/1563-0625-ISO-3291
Abstract
Pterygium is a fibrous neoplasm of the conjunctiva, which may have different pathomorphological characteristics depending on the region of residence. It is necessary to take into account regional factors that serve as local predictors of the risk of occurrence, course of the disease and relapse of the disease. Risk factors include insolation, harmful working conditions, climatic conditions. The purpose of the study was to study the morphological features of pterygium, determine the spectrum of cytokines and growth factors in biopsy tissues of patients with pterygium in the Southern Urals. A total of 68 eyes with a diagnosis of primary pterygium were operated for the period 2005 to 2025. Patients of both sexes aged 41 to 80 years. Morphological (hematoxylin and van Gieson staining) and immunohistochemical (FGF-b, Nf-h, PCNA, TGF-b, MMP-9, Timp-2, c-kit, Pro-col3, Col 1, HLA-DR, CD206, TNFa, VEGF-R, p-53) studies of biopsy specimens were performed. Statistical analysis of cell counts was performed using nonparametric methods in Statistica 10.0 software. It was found that the ratio of the fibrous component to the vascular-cellular component varied. In some tissues of the primary pterygium, signs of active collagenogenesis were detected, while in others, active proliferative activity was observed. Thus, in some pterygium tissues, the ratio of stromal elements to the vascular-cellular component shifted towards the latter. The stroma contained a large number of blood and lymphatic vessels with dilated lumens, intense tissue infiltration by stromal (fibroblastic) and inflammatory (macrophages, leukocytes, lymphocytes) cells, thin bundles of collagen fibers with a large amount of amorphous substance. Morphologically, pterygia were divided into three types: proliferative, fibromatous and atrophic-sclerotic. The proliferative group of pterygia contained more M2 macrophages of the CD206 phenotype, mesenchymal stem cells c-kit, MMP-9+ and VEGF-R+ cells than in fibromatous and atrophic-sclerotic types. Expression of FGF-b, HLA-DR, p-53 by cells was observed in all types of pterygium to the same equal extent. In proliferative pterygium, the amount of mature collagen type 1 exceeded the quantitative values of fibromatous and atrophic-sclerotic types. And the amount of immature reticular collagen type III and profibrogenic growth factor TGF-b in cells, on the contrary, significantly statistically significantly increased as tissue fibrosis progressed. Therefore, it is necessary to level or correct immunodeficiency, eliminate autoimmune complexes, reprofile macrophages from growthstimulating M2 to proinflammatory M1, stimulate TIMP-2, and inhibit conjunctival vasculogenesis.
About the Authors
A. I. LebedevaRussian Federation
Anna I. Lebedeva - PhD, MD (Biology), Head, Morphology Department
67/1 R. Zorge St Ufa, Republic of Bashkortostan 450075
R. Z. Kadyrov
Russian Federation
PhD, MD (Biology), Deputy Director for Medicine, Ophthalmologist
Ufa
L. A. Musina
Russian Federation
PhD, MD (Biology), Leading Research Associate, Morphology Research Department
Ufa
A. R. Khakimov
Russian Federation
Junior Research Associate, Morphology Research Department
Ufa
G. I. Yusupova
Russian Federation
Ophthalmologist
Ufa
References
1. Rashchupkin I.M., Maksimova A.A., Sakhno L.V., Ostanin A.A., Shevela E.Y., Chernykh E.R. Effect of M2 macrophage-derived soluble factors on proliferation and apoptosis of Sh-Sy5y сells. Bulleten experimentalnoy biologii i meditsiny = Bulletin of Experimental Biology and Medicine, 2021, Vol. 171, no. 1, pp. 45-48. (In Russ.)
2. Chumakov P.M. Protein p53 and its universal functions in a multicellular organism. Uspekhi biologicheskoy khimii = Advances in Biological Chemistry, 2007, Vol. 47, pp. 3-52. (In Russ.)
3. Yankovskaya A.A., Sakhno L.V., Shevela E.Ya. Comparative characteristics of mmr-9 and timp-1 production by different macrophage subtypes. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2019, Vol.13, no. 2, pp. 997-998. (In Russ.) doi: 10.31857/S102872210006493-7.
4. Bernauer W., Wright P., Dart J.K., Leonard I.N., Lightman S. Cytokines in the conjunctiva of acute and chronic mucous membrane pemphigoid: an immunohistochemical analysis. Graefes Arch. Clin. Exp. Ophthalmol., 1993, Vol. 231, no. 10, pp. 563-570.
5. Bradley J.C., Yang W., Bradley R.H., Reid T.W., Schwab I.R. The science of pterygia. Br. J. Ophthalmol., 2010, Vol. 94, no. 7, pp. 815-820.
6. Fonseca E.C., Rocha E.M., Arruda G.V. Comparison among adjuvant treatments for primary pterygium: a network meta-analysis. Br. J. Ophthalmol., 2018, Vol. 102, no. 6, pp. 748-756.
7. Di Girolamo N., Chui N., Coroneo J., Wakefield M.T. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog. Retin Eye Res., 2004, Vol. 23, no. 2, pp. 195-228.
8. Jaynes J.M., Sable R., Ronzetti M., Bautista W., Knotts Z., Abisoye-Ogunniyan A., Li D., Calvo R., Dashnyam M., Singh A., Guerin T., White J., Ravichandran S., Kumar P., Talsania K., Chen V., Ghebremedhin A., Karanam B., Bin Salam A., Amin R., Odzorig T., Aiken T., Nguyen V., Bian Y., Zarif J.C., de Groot A.E., Mehta M., Fan L., Hu X., Simeonov A., Pate N., Abu-Asab M., Ferrer M., Southall N., Ock C.Y., Zhao Y., Lopez H., Kozlov S., de Val N., Yates C.C., Baljinnyam B., Marugan J., Rudloff U. Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. Sci. Transl. Med., 2020, Vol. 12, no. 530, eaax6337. doi: 10.1126/scitranslmed.aax6337.
9. Lee J.K., Song Y.S., Ha H.S., Park J.H., Kim M.K., Park A.J., Kim J.C. Endothelial progenitor cells in pterygium pathogenesis. Eye (Lond.), 2007, Vol. 21, no. 9, pp. 1186-1193.
10. Lee S.J., Koh A., Lee S.H., Kim K.W. Distinct activation of M1 and M2 macrophages in the primary pterygium lymphangiogenesis. Exp. Eye Res., 2024, Vol. 248, 110108. doi: 10.1016/j.exer.2024.110108.
11. Phillips G.D., Whitehead R.A., Stone A.M., Ruebel M.W., Goodkin M.L., Knighton D.R. Transforming growth factor beta (TGF-B) stimulation of angiogenesis: an electron microscopic study. J. Submicrosc. Cytol. Pathol., 1993, Vol. 25, no. 2, pp. 149-155.
12. Rahabi M., Jacquemin G., Prat M., Meunier E., AlaEddine M., Bertrand B., Lefèvre L., Benmoussa K., Batigne P., Aubouy A., Auwerx J., Kirzin S., Bonnet D., Danjoux M., Pipy B., Alric L., Authier H., Coste A. Divergent Roles for Macrophage C-Type Lectin Receptors, Dectin-1 and Mannose Receptors, in the Intestinal Inflammatory Response. Cell Rep., 2020, Vol. 30, pp. 4386-4398.
13. Robert S., Gicquel Т., Victoni T., Valença S., Barreto E., Bailly-Maître B., Boichot E., Lagente V. Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis. Biosci. Rep., 2016, Vol. 36, no. 4, e00360. doi: 10.1042/BSR20160107.
14. Sica A., Mantovani А. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest., 2012, Vol. 122, pp. 787-795.
15. Tarique A.A., Logan J., Thomas E., Holt P.G., Sly P.D., Fantino E. Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. Am. J. Respir. Cell. Mol. Biol., 2015, Vol. 53, no. 5, pp. 676-688.
16. Tsironi S., Ioachim E., Machera M., Aspiotis M., Agnantis N., Psillas K. Immunohistochemical HLA-DR antigen expression with lymphocyte subsets and proliferative activity in pterygium. In Vivo, 2002, Vol. 16, no. 5, pp. 299-306.
17. Turan M., Turan G. Bcl-2, p53, and Ki-67 expression in pterygium and normal conjunctiva and their relationship with pterygium recurrence. Eur. J. Ophthalmol., 2020, Vol. 30, no. 6, pp. 1232-1237.
18. Ye J., Song Y.S., Kang S.H., Yao K., Kim J.C. Involvement of bone marrow-derived stem and progenitor cells in the pathogenesis of pterygium. Eye (Lond.), 2004, Vol. 18, no. 8, pp. 839-843.
Review
For citations:
Lebedeva A.I., Kadyrov R.Z., Musina L.A., Khakimov A.R., Yusupova G.I. Immunohistochemical study of various types of pterygium in patients of the Southern Urals. Medical Immunology (Russia). 2026;28(2):367-374. (In Russ.) https://doi.org/10.15789/1563-0625-ISO-3291
JATS XML





































